ClinicalTrials.govpublic full text
NF-κB Inhibition in Amyotrophic Lateral Sclerosis
als, withania somnifera, ashwagandha, nuclear factor kappa beta inhibition, amyotrophic lateral sclerosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832518
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.